Retatrutide has emerged as a new medication in the fight against obesity. This revolutionary drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By activating these https://chiaraagtj196534.link4blogs.com/57323807/tirzepatide-a-promising-new-treatment-for-obesity